Drug Profile
Azodicarbonamide - H-Phar / Universite Libre de Bruxelles
Alternative Names: ADA; HPH-116; NSC 674447Latest Information Update: 13 Nov 2021
Price :
$50
*
At a glance
- Originator Universite Libre de Bruxelles
- Developer H-Phar; Universite Libre de Bruxelles
- Class Amides; Antiretrovirals; Aza compounds; Small molecules
- Mechanism of Action HIV zinc finger inhibitors; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II HIV infections
- No development reported Transplant rejection
Most Recent Events
- 09 Jul 2019 Azodicarbonamide is still in phase II trials for HIV infections in Spain(EudraCT 2007-000950-30)
- 17 Aug 2015 Phase-II development is ongoing in Spain for HIV infections
- 30 Aug 2011 Azodicarbonamide is still in phase II trials for HIV infection in Spain